Skip to contentApplication 200880
- Type
- ANDA
- Sponsor
- MYLAN ASI
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-817 | Acetazolamide | acetazolamide sodium | Sagent Pharmaceuticals | ANDA | Current |
| 67457-853 | Acetazolamide | acetazolamide sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-853 | Acetazolamide | acetazolamide sodium | Mylan Institutional LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 43357 | ORIG | 2012-10-09 |